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Abstract 
The reactions are reported of NbX5 (X= Cl, Br), TiCl4 and Ti(O
iPr)4 with a selection of carboxylic 
acids exhibiting a known biological role, in a chlorinated solvent. The reactions of NbX5 with 
acetylsalicylic acid (aspirin) proceeded with selective deacetylation of the organic reactant and 
formation of the salicylate complexes NbX4(C7H5O3) (1a, X = Cl; 1b, X = Br) in 60-65% yields. 
NbCl5 reacted with diclofenac and ethacrynic acid (EA-CO2H) to give NbCl3[κ
3
O,O,N-
O2CCH2(C6H4)NC6H3Cl2], 2 (80% yield), and NbCl4(O2C-EA), 3 (72% yield), respectively. 
Ti(OiPr)4 reacted with ethacrynic acid giving Ti(O
iPr)2(O2C-EA)2, 4, in 74% yield, as a mixture of 
two isomers. All the products were characterized by means of analytical and spectroscopic methods, 
moreover DFT studies were carried out to give insight into structural features. 
 
Keywords: niobium pentahalides, titanium tetrachloride, titanium isopropoxide, coordination 
chemistry, bioactive carboxylic acids 
 
1. Introduction 
Amongst the three important classes of transition metal derivatives containing a M−O−C bond (i.e. 
metal alkoxides, β-diketonates and carboxylates), metal carboxylates have been known for the 
longest time [1]. The reactions of transition metal chlorides with acetic acid and related halo-α-
substituted compounds usually take place via the release of hydrogen chloride and may represent an 
entry into the rich chemistry of carboxylato complexes [1, 2]. This reactivity has been ascertained, 
inter alia, for oxophilic halides of metals belonging to the groups 4 [3] and 5 [4]. More precisely, 
the reactions of several carboxylic acids or the corresponding alkali salts with titanium(IV) halides 
are known to yield derivatives of general formula TiX4-n(O2CR)n (n = 1-4, X = Cl, Br) [3]. The 
latter have been used as catalytic precursors for olefin polymerization [5] and for the synthesis of 
TiO2-based nano-crystalline materials [6], compounds with antiwear properties [7] or exhibiting 
solvent absorption and desorption properties [8]. Moreover, recently, titanium carboxylates have 
aroused interest for their possible biological activity [9] and, thus, for biomedical purposes [10]. 
Niobium and tantalum pentahalides remained for a long time in the shadow of metal complexes of 
group 4, probably in the light of the extraordinary applications of the latter in alkene chemistry [11]. 
However, in the last fifteen years, a significant progress has been traced concerning the chemistry 
of niobium and tantalum pentahalides [11, 12], encouraged by their easy availability, the relative 
nontoxicity of the metal elements [13], and the unusual reactivity patterns [12e,h, 14]. As far as 
metal carboxylates are concerned, adducts of the type MCl4(OOCR) (M = Nb, Ta, R = alkyl or 
haloalkyl substituents) [4c, 4d, 15], beside a variety of oxo-chloride species of general formula 
MOCl(OOCR)2 [15a,15b,15c], MOCl2(OOCR) [15a] and MO2(OOCR) [15c], were obtained from 
the reactions of MCl5 with RCOOH or (RCO)2O. On the other hand, the reactions of aryl carboxylic 
acids (ArCO2H) with MCl5 generally result in the formation of dinuclear carboxylato-bridged 
species, M2Cl8(OOCAr)2 (M = Nb, Ta, Ar = aryl) [16]. 
In this context, the exploration of the chemistry of early transition, high valent metal compounds 
with carboxylic acids containing additional functional groups still remains in its infancy. This is 
presumably a consequence of the variety of complicated reaction pathways that may be working 
when such oxophilic metal species are allowed to contact with oxygen functions [12h, 17]. 
In view of this, and of the great interest aroused by the interaction of metal ions with bioactive 
molecules, finding extensive application for pharmacological issues [18], herein we describe a work 
on the reactivity of NbX5 (X = Cl, Br), TiCl4 and Ti(O
iPr)4 with some carboxylic acids with a 
known biological role (Figure 1) [19]. The formation of coordination compounds, their structural 
characterization by means of spectroscopic and computational studies, and the NbCl5-induced 
deacetylation of aspirin will be discussed.  
diclofenac
(DF-COOH)
Cl
Cl
COOH
O
ethacrynic acid
EA-COOH
COOH
O
O
acetylsalicylic acid
COOH
H
N
Cl
Cl
 
Figure 1. Bioactive carboxylic acids treated in this work. 
 
2. Results and Discussion 
The reactions of NbX5 (X = Cl, Br) with acetylsalicylic acid led to the isolation of dark red solid 
compounds of formula NbX4(C7H5O3) (1a, X = Cl; 1b, X = Br), according to elemental analysis. 
Both the reactions proceeded with the release of the corresponding acetyl halide, as evidenced by 
NMR (see Experimental). After hydrolysis of the reaction mixtures [20, 21], salicylic acid was 
cleanly recovered as unique organic species, and detected by IR and NMR spectroscopy. 
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Scheme 1. Reaction of NbX5 (X = Cl, Br) with acetylsalicylic acid. 
 
The deacetylation of aryl acetates to phenols is a well known reaction [22], and actually the most 
important way of action of acetylsalicylic acid (aspirin) is to irreversibly acetylate amino-acids in 
the human body [23]. Nevertheless, the outcome of the reaction described in Scheme 1 is surprising 
since it proceeds with selective chlorination of the ester function, while NbCl5 usually coordinates 
(and not activate) esters at ambient temperature [24]. On the other hand, other high valent transition 
metal chlorides easily convert carboxylic acids into the corresponding acyl chlorides [17a, 25]. The 
analogous reaction between PCl5, selected as a representative main group pentachloride, and 
acetylsalicylic acid led to chlorination of the carboxylic acid group, preserving the acetato moiety 
(Scheme 2) [26]. 
 Scheme 2. Reaction of PCl5 with acetylsalicylic acid. 
 
The niobium derivatives 1a-b were characterized by IR and NMR spectroscopy. The IR spectra do 
not show any absorption around 1750 cm−1, diagnostic for the acetyloxy group belonging to 
acetylsalicylic acid, thus confirming the loss of this fragment. On the other hand, two strong 
absorptions have been observed around 1500 and 1380 cm−1. These have been attributed, 
respectively, to the asymmetric (νas) and the symmetric (νs) stretching vibration of the metal-
coordinated carboxylate. In general, the wavenumber difference (∆νas−s = νas−νs) is considered as a 
useful parameter to discriminate between monodentate, chelating, and bridging bidentate 
carboxylato ligands. ∆νas−s values within the range 100 to 150 cm
−1 are typical of either chelating or 
bridging bidentate carboxylates [27]. The IR data available for 1a-b, i.e. ∆νa−s is 112 (1a) and 126 
(1b) cm−1, are consistent with a bidentate coordination fashion, thus two possible structures can be 
envisaged in principle (Figure 2).  
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Figure 2. Possible structures of niobium(V) tetrahalide salicylate complexes (X = Cl, Br). 
 
Many attempts were done to collect X-ray quality crystals of 1a-b, but unsuccessfully. Therefore, 
we decided to perform a DFT investigation on 1a to elucidate its structure. The dimeric structure 
with two bridging carboxylato ligands (Figures 2-II and 3) resulted more stable than the 
mononuclear κ2-carboxylate complex (Figures 2-I and S1) by about 6.2 kcal mol-1 (Gibbs free 
energy, referred to the mononuclear stoichiometry). In both cases, the hydroxyl group is expected to 
participate to intramolecular hydrogen bonding. According to the computational result, it is 
reasonable that 1a and the homolog compound 1b adopt the dimeric structure, that is reminiscent of 
what previously described for other MX4(OOCAr) compounds (M = Nb, Ta; Ar = aryl group) [16]. 
 
 
Figure 3. DFT-optimized structure of the most stable isomer of 1a (C-PCM/ωB97X calculations). After geometry 
optimization, the molecule has C2 symmetry. Selected bond lengths (Å): Nb-O 1.992, 2.144; Nb-Cl 2.284, 2.308, 2.316, 
2.353; C-O 1.267, 1.284; O-H 0.972; H---O 1.817. Selected angles (deg): O-Nb-O 87.3; C-O-Nb 140.7, 156.0. Colour 
map: Nb, light blue; Cl, green; O, red; C, grey; H, light gray. 
 
A control of the literature data has shown that 1a,b constitute the first examples of niobium(V) 
halides containing salicylate as a ligand, other similar cases being referred to alkoxide derivatives 
[28]. 
The 1H and 13C NMR spectra of 1a, b display several resonances in the aromatic region. This fact 
may be due to the presence of isomeric forms, or to intermolecular interactions promoted by the OH 
groups. The 93Nb NMR spectrum of 1a clearly consists of a unique, broad resonance at −271 (∆ν½ 
= 4⋅103 Hz) ppm [29]. 
NbCl5 quickly reacted with diclofenac in dichloromethane affording a red solution which, on 
standing at RT for 48 h, gave a yellow precipitate. This solid was identified as NbCl3[κ
3
O,O,N-
O2CCH2(C6H4)NC6H3Cl2], 2, i.e. a niobium(V) complex containing a tridentate, dianionic, OON-
coordinated ligand (Scheme 3). The characterization was based on analytical, IR (two strong 
absorptions have been observed around 1599 and 1458 cm−1 due to asymmetric and symmetric (νs) 
stretching vibrations of the carboxylato group) and NMR data. The 1H NMR spectrum displayed a 
single set of resonances, and N-bound hydrogens were not recognized. The 93Nb NMR spectrum 
(broad resonance centered at −564 ppm) ruled out the possible existence of an ionic pair including 
[NbCl6]
− [25b,c, 29, 30, 31], and suggested 2 to be a symmetric compound. 
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Scheme 3. The reaction of NbCl5 with diclofenac. 
 
According to DFT calculations, the lowest energy form of 2 is a dinuclear structure where the 
organic ligand coordinates the metal centers in a bridging fashion via the carboxylate group, 
similarly to what discussed for 1a. The enthalpy variation associated to the dimerization of 
pentacoordinate NbCl3[O2CCH2(C6H4)NC6H3Cl2] (Figure S2) is around −17.1 kcal mol
-1. 
 
Figure 4. DFT-optimized structure of the most stable isomer of 2 (C-PCM/ωB97X calculations). After geometry 
optimization, the molecule has approximately Ci symmetry. Selected bond lengths (Å, average values): Nb-O 2.065, 
2.108 2.144; Nb-Cl (trans N) 2.412; Nb-Cl (cis N) 2.341, 2.342; C-O 1.256, 1.263. Selected angles (deg, average 
values): O-Nb-O 82.3; N-Nb-Cl 93.5, 114.0, 157.6. C-O-Nb 132.8, 142.7. Colour map: Nb, light blue; Cl, green; O, red; 
C, grey; H, light gray. 
 
The reaction of niobium pentachloride with ethacrynic acid (EA-COOH) resulted in the formation 
of a moisture-sensitive orange precipitate, which was characterized as the Nb(V) ethacrynate 
NbCl4(O2C-EA), 3. The low solubility in common organic solvents precluded the growth of single 
crystals. The IR spectrum of 3 (in the solid state) shows a strong absorption at 1674 cm-1, assigned 
to the combination of the asymmetric stretching absorption of the carboxylate and the non-
coordinated ketone (the C=O stretching vibration of the ketonic group of EA-CO2H falls at 1670 
cm-1), and a medium to strong absorption at 1462 cm-1, assigned to the symmetric stretching 
vibration of the carboxylate. 
The presence of the intact EACOO unit within complex 3 is witnessed by the fact that, upon 
hydrolysis [20], EACOOH was cleanly recovered and identified by NMR spectroscopy. 
DFT calculations suggested a coordination mode of the ethacrynate moiety comparable to that 
proposed for the carboxylato ligands in 1a and 2, i.e. the carboxylic group acting as a bridging 
ligand between two niobium centers (see Figure 5). This feature is in alignment with previous 
findings in the literature [16]. Alternative, mononuclear structures with a κ2-ethacrynate ligand or 
dinuclear structures with Cl-bridges resulted to be computationally less stable isomers (Figure S3). 
 
Figure 5. DFT-optimized structure of the most stable isomer of 3 (C-PCM/ωB97X calculations). After geometry 
optimization, the molecule has approximately C2 symmetry. Selected bond lengths (Å, average values): Nb-O 2.023, 
2.132; Nb-Cl 2.279, 2.291, 2.325, 2.330; C-O 1.250, 1.260. Selected angles (°, average values): O-Nb-O 84.9; C-O-Nb 
139.9, 171.5. Colour map: Nb, light blue; Cl, green; O, red; C, grey; H, light gray. 
 
The reactions of TiCl4 with diclofenac and acetylsalicylic acid were studied too, but they afforded 
insoluble solid materials which could not be identified.  
We decided then to extend the present research to the reactivity of titanium alkoxide with 
ethacrynic acid. In general, Ti(OiPr)4 reacts with carboxylic acids giving replacement of one or 
more alkoxide ligands by an equal number of carboxylate units [32]. This kind of titanium alkoxide 
derivatives have been proposed as possible antitumoral agents [33]. 
The reaction of Ti(OiPr)4 with two equivalents of ethacrynic acid in refluxing CHCl3 afforded good 
yields of Ti(OiPr)2(O2C-EA)2, 4, as an ivory solid stable in air for short periods of time (Scheme 4). 
 
 
Scheme 4. Reaction of Ti(OiPr)4 with ethacrynic acid  
 
It is interesting to note that the use of EA-COOH / Ti molar ratio = 3 or 4 did not change the nature 
of the prevalently isolated product. 
 Compound 4 was characterized by analytical and spectroscopic data. The IR spectrum shows two 
strong absorptions at 1614 and 1467 cm−1, assigned to the asymmetric (νas) and the symmetric (νs) 
stretching vibrations of the carboxylato group. The value ∆νas−s = νas − νs of 147 cm
−1 is indicative 
of either a chelating or a bridging bidentate carboxylate [27]. On account of the IR spectrum and 
the DFT results (vide infra), we propose a bidentate coordination of the ethacrynate ligand to the 
titanium fragment. 
The 1H relative integration of the signals of the iso-propoxy and the ethacrynate moieties suggests 
that these are present in 1:1 molar ratio, reflecting the Ti(OiPr)2(O2C-EA)2 stoichiometry. The 
1H- 
and 13C-NMR spectra of 4 consist of two set of resonances of comparable intensity, presumably due 
to the co-existence of isomeric forms. Based on the analytical data, we presume that 4 is in fact a 
mixture of two linkage isomers, namely 4a and 4b.  
DFT calculations with implicit solvation ruled out the possibility of cis/trans isomerism; indeed all 
the geometry optimizations afforded stationary points wherein the two iso-propoxy ligands are 
mutually cis. Equilibrium geometries with comparable Gibbs free energy values (∆G = 2.3 kcal 
mol−1) are instead differentiated in the coordination mode of one of the two ethacrynate ligands. 
The favorable coordination mode resulted to be κ1 in the most stable species and κ2 in the 
secondary one, despite the fact that one Ti−O bond appeared relatively weak (calculated bond 
length = 2.309 Å). The second O2C-EA ligand should be bidentate in both the isomers. Figure 6 
shows the DFT-optimized structures of 4a and 4b.  
 
Figure 6. DFT-optimized isomers of compound 4 (C-PCM/ωB97X calculations, hydrogen atoms omitted for clarity). 
Selected bond lengths (Å) for 4a: Ti-O(iPrO) 1.724, 1.725; Ti-O(κ2-COO) 2.074, 2.187; Ti-O(κ1-COO) 1.911; C-O(κ2-
COO) 1.249, 1.272; C-O(κ1-COO) 1.214, 1.308. Selected angles (°) for 4a: O(iPrO)-Ti-O(iPrO) 106.5; O(κ1-COO)-Ti-
O(iPrO) 99.5, 106.3; O(κ1-COO)-Ti-O(κ2-COO) 84.5, 138.9; O(k2-COO)-Nb-O(k2-COO) 61.0. Selected bond lengths 
(Å) for 4b: Ti-O(iPrO) 1.738, 1.740; Ti-O(κ2-COOL1) 2.064, 2.145; Ti-O(κ2-COOL2) 2.012, 2.309; C-O(κ2-COOL1) 
1.257, 1.266; C-O(κ2-COOL2) 1.243, 1.281. Selected angles (°) for 4b: O(iPrO)-Ti-O(iPrO) 102.4; O(k2-COOL1)-Nb-
O(k2-COOL1) 61.9; O(k2-COOL2)-Nb-O(k2-COOL2) 60.1. Colour map: Ti, blue; Cl, green; O, red; C, grey; H, light gray. 
 
3. Conclusions 
Despite the chemistry of middle to late transition metal halides with carboxylic acids has been 
largely investigated, relatively little is known about the analogous reactions of high valent, early 
transition metal species. Herein, we have described the study of the reactivity of NbX5 (X = Cl, Br) 
and Ti(OiPr)4 with a selection of carboxylic acids exhibiting a known biological role. The reactions 
proceed to afford metal compounds containing bidentate carboxylates, whose structures have been 
elucidated by means of spectroscopic and computational analyses. One or more HX units (X = Cl, 
Br, OiPr) are generally lost during the reactions, moreover selective deacetylation of the organic 
moiety occurs during the interaction NbX5/aspirin. This latter case traces a clear distinction with the 
parallel reactivity displayed by the main group homologue PCl5. 
 
Scheme 5. Overview of the reactivity of NbCl5 with bioactive carboxylic acids. 
 
4. Experimental 
All manipulations of air and/or moisture-sensitive compounds were performed under an 
atmosphere of pre-purified nitrogen using standard Schlenk techniques. The reaction vessels were 
oven dried at 150 °C prior to use, evacuated (10−2 mmHg) and then filled with argon. 
TiCl4 (99%, Strem), NbCl5 (99+%, Strem), Ti(OiPr4) (98%, Strem), PCl5 (>98%, Sigma 
Aldrich), Ag2O (99+%, Sigma Aldrich) and organic reactants (highest purity available, from TCI 
Europe or Sigma Aldrich) were commercial products stored under nitrogen atmosphere as received. 
NbBr5 was prepared according to the literature procedure and stored under nitrogen atmosphere 
[34]. Once isolated, the metal products were conserved in sealed glass tubes under nitrogen. 
Solvents (Sigma-Aldrich) were distilled from appropriate drying agents. Reflectance infrared 
spectra of solid materials were recorded at 298 K on a FT IR-Perkin Elmer Spectrometer, equipped 
with a UATR sampling accessory. NMR spectra were recorded at 293 K on a Bruker Avance II 
DRX400 instrument equipped with a BBFO broadband probe. The chemical shifts for 1H and 13C 
were referenced to the non-deuterated aliquot of the solvent, while the chemical shifts for 93Nb were 
referenced to [NEt4][NbCl6] as an external reference. Carbon, hydrogen and nitrogen analyses were 
performed on a Carlo Erba mod. 1106 instrument. The halide content was determined by the Mohr 
method [35] on solutions prepared by dissolution of the solid samples in aqueous KOH and heated 
at boiling temperature for 72 hours, followed by cooling to room temperature and addition of HNO3 
up to neutralization. 
 
4.1. Reactions of Nb(V) halides with acetylsalicylic acid: synthesis of NbX4[κ
2
-C6H4(O)(CO2H)] (X 
= Cl, 1a; X = Br, 1b). The synthesis of 1a is described in detail, 1b being prepared by a similar 
procedure. NbCl5 (240 mg, 0.888 mmol), acetylsalicylic acid (160 mg, 0.888 mmol) and CH2Cl2 
(15 mL) were introduced into a Schlenk tube in the order given. The mixture was allowed to stir at 
room temperature for 48 h. The resulting red solution was concentrated up to 5 mL, layered with 
pentane and stored at −30 °C for one week. The product, 1a, was recovered as a dark red 
microcrystalline solid. Yield 215 mg, 65%. Anal. Calc. for C7H5Cl4NbO3: C, 22.61; H, 1.36; Cl, 
38.14. Found: C, 22.50; H, 1.63; Cl, 38.05. IR (solid state, cm–1): 2898vw, 2129w, 1597s, 1577vs, 
1506s, 1434m, 1393vs, 1375vs, 1312m, 1265m, 1230s, 1165m, 1104m, 1099m, 1031w, 902s, 
857w, 799w-m, 753vs, 691w, 673s cm-1. 1H NMR (CDCl3): δ = 11.5 (br, 1 H, OH); 8.28, 7.93, 
7.43, 7.15 (m-br, 4 H, arom CH) ppm. 13C NMR (CDCl3): δ = 173.1 (COO); 162.4 (arom C-O); 
139.5, 133.2, 127.2, 118.4 (arom CH); 119.0 (arom C-C) ppm. 93Nb NMR (CDCl3): δ = −271 (∆ν½ 
= 4⋅103 Hz) ppm. 
1b. Dark red solid, from NbBr5 (300 mg, 0.609 mmol) and acetylsalicylic acid (110 mg, 0.611 
mmol). Yield 201 mg, 60%. Anal. Calc. for C7H5Br4NbO3: C, 15.30; H, 0.92; Br, 58.15. Found: C, 
15.22; H, 1.05; Br, 57.93. IR (solid state, cm–1): 3070w-br, 2922w, 2853w, 1603s, 1589s, 1556m, 
1504m, 1481m, 1428w, 1367s 1325w, 1312w, 1228m, 1207m, 1162m, 1098m, 1030w, 898s, 854w-
m, 796s, 755vs, 691m, 666vs cm-1. 1H NMR (CDCl3): δ = 10.3 (br, OH); 8.53, 8.28, 7.93, 7.58-
7.43, 7.34-7.17 (m, arom CH) ppm. 13C NMR (CDCl3): δ = 172.0 (COO); 161.3 (C-OH); 139.6-
138.8, 134.0-132.7, 128.8-127.3, 119.0-118.2 (arom) ppm. 
The reactions of NbX5 with acetylsalicylic acid were also performed in CD2Cl2 under conditions 
analogous to those described above. NMR analysis of the reaction solutions after 30 hours clearly 
indicated the formation of acetyl chloride. 
 
4.2. Reaction of NbCl5 with diclofenac: synthesis of NbCl3[κ
3
O,O,N-O2CCH2(C6H4)N C6H3Cl2], 2. 
The reaction of NbCl5 (464 mg, 1.71 mmol) with diclofenac (506 mg, 1.71 mmol) was carried out 
by a procedure analogous to that described for NbCl5/acetylsalicylic acid. The progressive 
formation of an abundant, yellow precipitate occurred. Compound 2 was finally isolated as a yellow 
solid. Yield 675 mg, 80%. Anal. Calc. for C14H9Cl5NNbO2: C, 34.08; H, 1.84; N, 2.84; Cl 
(inorganic), 21.56. Found: C, 34.21; H, 1.70; N, 2.76; Cl (inorganic), 22.15. IR (solid state, cm–1): 
2941w, 2909w, 1633m, 1599vs (νasCOO), 1570m, 1496w, 1458m (νsCOO), 1440m, 1398w, 
1362m, 1300w, 1262w, 1200m, 1097w, 997w, 943w, 779vs, 750s, 737m-s, 709m, 686s cm-1. 1H 
NMR (CD3CN): δ = 7.68, 7.57, 7.47, 7.28, 7.19, 6.52 (m, 7 H, arom CH); 3.86 (s, 2 H, CH2) ppm. 
93Nb NMR (CD3CN): δ = −564 (∆ν½ = 2⋅10
3 Hz) ppm.  
 
4.3. Reaction of NbCl5 with ethacrynic acid: synthesis of NbCl4(O2C-EA), 3. 
NbCl5 (141 mg, 0.522 mmol), ethacrynic acid (158 mg, 0.521 mmol) and CH2Cl2 (8 mL) were 
introduced into a Schlenk tube in the order given. A red solution was immediately obtained and the 
precipitation of an orange compound began shortly afterwards. The suspension was stirred at room 
temperature for 4 h. Compound 3 was obtained as a moisture-sensitive orange solid upon removal 
of the solvent under reduced pressure. Yield 203 mg, 72%. The product is insoluble in toluene and 
chlorinated solvents, and is not stable in acetonitrile or diethyl ether. Anal. Calc. for 
C26H22Cl12Nb2O8: C, 29.08; H, 2.06; Cl (inorganic), 26.42. Found: C, 28.80; H, 2.17; Cl, 28.90. IR 
(solid state): ν = 2973w, 2939w, 2878 w, 1675s-br (νas,CO2 + νC=O, keto), 1642w-sh, 1583s (νC=CH2), 
1464s (νs,CO2), 1431m, 1387m, 1338w, 1286m, 1261m, 1240m, 1217m, 1166w, 1128m, 1100s, 
1087s, 1070s, 972w, 943w, 898s, 849w, 830m, 822m, 733m, 718m-sh, 687m. Rapid increase of 
absorption intensities at 3400-3000 (νOH) 1735 (νC=O,acid,EACO2H) and 1642 cm
-1 (δOH) was observed 
upon brief air exposition of the solid sample. 
 
4.4. Reactions of TiCl4 with diclofenac and acetylsalicylic acid. 
A solution of diclofenac (296 mg, 1.00 mmol) in CH2Cl2 (10 mL) was added of TiCl4 (1.89 mL, 
1.00 mmol). After 24 h, the liquors were removed and the abundant precipitate was washed with 
pentane and dried under vacuo, thus affording a yellow solid (yield 200 mg). IR (solid state, cm–1): 
3079w-br, 1645w, 1604w, 1542m, 1510s, 1500sh, 1454m, 1440m-s, 1404s, 1349w, 1276w, 1199w, 
1153w, 1098w-m, 947w, 902w-m, 781m-s, 756s, 724s, 708m, 690s, 654vs cm-1. 1H NMR 
(CD3CN): δ = 7.67-6.97 (m, arom CH); 6.54, 6.48 (br); 4.00, 3.80 (br, CH2) ppm. 
The reaction of TiCl4 (1.00 mmol) with acetylsalicylic acid (1.00 mmol) was carried out by a 
procedure analogous to that described for TiCl4/diclofenac, and a red solid was finally isolated 
(yield ca. 150 mg). IR (solid state, cm–1): 1599s, 1575s, 1557m-s, 1489s, 1474s, 1442s, 1377vs, 
1313m-s, 1265m, 1251m-s, 1223vs, 1163m, 1152m, 1096m, 1031w-m, 961w, 891vs, 870m, 858m, 
819w-m, 789m, 760vs, 694m, 666vs cm-1. 
 
4.5. Identification of the organic species. 
Diethyl ether (ca. 5 mL) and then H2O (ca. 2 mL) were added to the appropriate metal product (ca. 
0.5 mmol). The mixture was stirred at room temperature for 48 h. Then the organic phase was 
separated and dried in vacuo. The following compounds were detected by NMR spectroscopy as the 
only organic species. From 1a-b: salicylic acid; from 1: diclofenac; from 2: ethacrynic acid; from 3: 
ethacrynic acid; from TiCl4/diclofenac: diclofenac; from TiCl4/aspirin: aspirin. Salicylic acid was 
identified by IR in the solid state too [36]. 
 
4.6. Reaction of Ti(OiPr)4 with ethacrynic acid: synthesis of Ti(O
i
Pr)2(O2C-EA)2, 4. 
Cl
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O
O
O
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Ti(EA-COO)(OiPr)2
 
A solution of Ti(OiPr)4 (0.1 ml, 0.33 mmol) in CHCl3 (20 ml) was treated with ethacrynic 
acid (0.201 g, 0.663 mmol) After 24 h heating to the reflux temperature, the mixture was cooled at 
room temperature and the volatiles were removed in vacuo at room temperature. The solid was 
washed with hexane and dried in vacuo a room temperature affording 0.188 g (74%) of 4 as a 
colorless solid. Anal. Calc. for C38H52Cl4O10Ti: C, 53.16; H, 6.10; Ti, 5.57. Found: C, 52.98; H: 
5.86; Ti, 5.08. IR (solid state, cm–1): 2969w, 2934w, 2107w-br, 1756w, 1664s (C=O), 1614m 
(νasCOO), 1583vs, 1574m-sh, 1467s (νsCOO), 1455s, 1421s, 1383m, 1339m, 1286s, 1259vs, 1206s 
1120m, 1076vs, 1001s, 938m, 894w, 800s, 755vs cm-1. 1H NMR (CDCl3): δ = 7.13 (d, 1 H, 
3JHH = 
8.80 Hz, C10-H); 6.78 (m, 1 H, C11-H); 5.93, 5.59 (d, 2 H, J = 1 Hz, C4-H); 5.13, 4.28 (m, 2 H, 
OCH); 4.75, 4.71 (s, 2 H, C12-H); 2.46 (m, 2 H, C2-H); 1.26, 1.13, 0.87 (m, 9 H, C1-H + 
OCHCH3) ppm. 
13C NMR (CDCl3): δ = 195.8 (C5); 167.8, 167.2 (C13); 155.6 (C9); 150.2 (C6); 
133.8 (C7), 131.4 (C8); 128.5 (C4); 126.7 (C11); 123.4 (C3); 110.8 (C10); 69.7, 61.7 (OCH); 66.4, 
66.3 (C12); 31.6, 22.6, 21.7, 14.1 (OCHCH3); 23.4 (C2); 12.4 (C1) ppm. 
 
5. Computational details 
The computational geometry optimizations were carried out without symmetry constrains, 
using the range-separated DFT functional ωB97X [37], in combination with the split-valence 
polarized basis set of Ahlrichs and Weigend, with ECP for the niobium centre [38]. The C-PCM 
implicit solvation model was added to ωB97X calculations, considering chloroform as continuous 
medium [39]. The “restricted” formalism was always applied. The stationary points were 
characterized by IR simulations (harmonic approximation), from which zero-point vibrational 
energies and thermal corrections (T = 298.15 K) were obtained [40]. The software used was 
Gaussian ’09 [41]. Further computational details are provided as Supporting Information. 
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